25May 2019

DEVELOPMENT AND OPTIMIZATION OF BI LAYERED FLOATING TABLET OF SUCRALFATE AND METOPROLOL SUCCINATE.

  • PG Department of Pharmaceutics, Indira Gandhi Institute of Pharmaceutical Sciences, Bhubaneswar.
  • Abstract
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author

Objective:To optimize and develop Bi layered floating tablet (SFMS) containing ulcer protective Sucralfate as immediate release layer and anti hypertensiveMetoprolol Succinate as sustained release layer. Method: 15 formulations of Sucralfate and 10 formulations of Metoprolol Succinate is taken. By changing the concentration of Superdisintigrant, Surfectants, Alkalizing agents & Binding agents of Sucralfate and changing concentrations of Alkalizing agents and Polymers of Metoprolol Succinate the OSFMS (Optimized Sucralfate and Metoprolol Succinate Formulation) is generated.. Result: Within 5 minutes in acidic medium , 7% Superdisintigant (Crosspovidone), 7% Surfectant (Polysorbate-80), 15% Alkalizing agents(Sodium bicarbonate), 5% HPC (Binding agent) averagely produce 68.56%drug release. Within 20 hours in acidic medium , 30% Alkalizing agents(Sodium bicarbonate) , 50% Soluablepolymer (HPMC K) ,40% Polymer (Udragid RSPO, 35% HPC Polymer(NaCMC), 30% Polymer (Sodiumalginate) ,25% Polymer (HPC) , 20% Polymer, Udragid RS), 5% HPC Polymer (PVPK) produce averagely100.06% drug release. Conclusion:The optimized formulation 400 mg tablet weight of OSFMS (Optimized Sucralfate and Metoprolol Succinate Formulation) produce better result and identified as better formulation for further studies.


  1. Optimizationtechniques.in.pharmaceutics.formulation-processing.2007; Avilable at- htpps//www.slideshare.net/mobile/MUHEEM-007/optimization-in
  2. Pathekar S , Suggala V, Ghopeap S ,Salunka R , Jain H , Swain K. Review on Bi-layer Floating Tablets .WJPPS 2016 ; 2 : 1411 ?13 .
  3. Arora S, Ali J , Ahuja A, Khar R.K, Mabota S. Floating Drug Delivery System ; A review. AAPS Pharma Science tech 2005 ; 3: E 372-89 .
  4. Verma R, Kishor D, Tushar G. Bi- Layer Tablet for Various Drugs : A review. SAJP 2014 ; 3: 271-79.
  5. Biswal B .Design development and evaluation of Trimetazidine Di hydrochloride Floating Bi-Layer M.R Tablet IRJP 2011 ; 7: 92-97.
  6. Garg R K ,Singhvi I. Bilayer Floating Tablet Technology : An Overview ; IJPPR 2015, 3: 302-22.
  7. Kardumpala S, Chetty M, Gnanaprakash K, Venkatesh B, Sankar P. A review on Bilayer Floating Tablets. IJRPS 2013; 2:354-60.
  8. Regardh CG, Lundborg P, Persson BA, The effect of antacid , metoclopramide,andpropantheline on the bioavilability of metoprolol and atenolol Biopharm Drug Dispos.1981 ; 2 :79-87
  9. Drug interaction between Metoprolol succinate ER and sucralfate. Avilable at- https:// drugs.com / drug interaction / metoprol Succinate ER with .sucralfate ? 1615? ? 14142 -2118 o.html ?professional =1
  10. Devlopment and Optimization of Bilayer Floating Tablets of Glipizide .RJPS 2013; (9):8-12.
  11. Rajendra K, Krishna M C, A Compresive Review OnGastroretaintive Drug Delivery System. AJPS2016; 3 (2): 115-128 .
  12. Das SR, Panigrahi BB, Pani MK. Formulation and Evaluation of Sucralfate and? Metoprol succinate Bi-Layer Floating Tablet as Gastro Retaintive Drug Delivery.

[Sreedhar Ranjan Das, Bibhuti Bhusan Panigrahi And Manoj Kumar Pani. (2019); DEVELOPMENT AND OPTIMIZATION OF BI LAYERED FLOATING TABLET OF SUCRALFATE AND METOPROLOL SUCCINATE. Int. J. of Adv. Res. 7 (May). 832-849] (ISSN 2320-5407). www.journalijar.com


Mr Sreedhar Ranjan Das
Research scholar

DOI:


Article DOI: 10.21474/IJAR01/9105      
DOI URL: https://dx.doi.org/10.21474/IJAR01/9105